Hellenic Registry of Ovation Altoâ„¢ Abdominal Stent Graft System
NCT ID: NCT05172830
Last Updated: 2021-12-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2021-01-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group/Cohort
Ovation Altoâ„¢ Abdominal Stent Graft System Eligible patients must meet all of the inclusion criteria and none of the exclusion criteria.
Ovation Altoâ„¢ Abdominal Stent Graft System
Single occurrence permanent implantation of AAA device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ovation Altoâ„¢ Abdominal Stent Graft System
Single occurrence permanent implantation of AAA device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both IFU and non-adherence to IFU
* Subject intends to electively receive the Ovation Altoâ„¢ Abdominal Stent Graft System
* Subject has the ability and willingness to comply with all follow-up exams as indicated in clinical investigation plan
Exclusion Criteria
* Life expectancy less than 1 year
* Pregnancy
* Subjects with poor renal function as indicated by a serum creatinine \> 2.5mg/dl.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Patras
OTHER
University Hospital of Crete
OTHER
University Hospital, Alexandroupolis
OTHER
Larissa University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Konstantinos Spanos
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Larisssa
Larissa, , Greece
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Konstantinos Spanos, PhD
Role: primary
Athanasios Giannoukas, Prof
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
986152150
Identifier Type: -
Identifier Source: org_study_id